Evidence map›Paper›PMID 26098442›Full record

Trial reportPain2015

Altered pain modulation in patients with persistent postendodontic pain.

Cibele Nasri-Heir, Junad Khan, Rafael Benoliel, Changyong Feng, David Yarnitsky, Fengshen Kuo, Craig Hirschberg, Gary Hartwell, Ching-Yu Huang, Gary Heir and 3 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pain, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05142228 (Erenumab as a Therapeutic Approach for the Management of Trigeminal Neuropathic Pain), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05142228 phase2terminatednot on this mapstarted 2022, after this paper: background citation

Erenumab as a Therapeutic Approach for the Management of Trigeminal Neuropathic Pain (TNP)

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2022 to 2022Enrolled5ConditionsTrigeminal NeuropathyArmsErenumab-Aooe, Placebo
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Doxazosin Alleviates Chronic Orofacial Pain.International journal of molecular sciences · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Can Intra-Oral Qualitative Sensory Testing Foretell Postoperative Dental Pain? A Preliminary Report.International journal of environmental research and public health · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Chronic orofacial pain.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Cibele Nasri-HeirDepartment of Diagnostic Sciences, Rutgers School of Dental Medicine, Newark, NJ, USA Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA Department of Neurology, Rambam Health Care Campus, Haifa, Israel Departments of Oral Biology and Endodontics, Rutgers School of Dental Medicine, Newark, NJ, USA Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.
Junad Khan
Rafael Benoliel
Changyong Feng
David Yarnitsky
Fengshen Kuo
Craig Hirschberg
Gary Hartwell
Ching-Yu Huang
Gary Heir
Olga Korczeniewska
Scott R Diehl
Eli Eliav
University of Rochester Medical Center · USRutgers, The State University of New Jersey · USRambam Health Care Campus · IL

Funding

ATYPICAL ODONTALGIA AND ENDODONTIC TREATMENT, SENSORY TESTING AND GENETIC STUDYR21DE017900 · NIDCR · UNIV OF MED/DENT OF NJ-NJ DENTAL SCHOOL · PI ELIAV, ELI · 2009 to 2010
$429k
NIDCR NIH HHS R21 DE017900NIDCR NIH HHS R21DE01790001A2
6 · The paper itself

Abstract

Persistent pain may follow nerve injuries associated with invasive therapeutic interventions. About 3% to 7% of the patients remain with chronic pain after endodontic treatment, and these are described as suffering from painful posttraumatic trigeminal neuropathy (PTTN). Unfortunately, we are unable to identify which patients undergoing such procedures are at increased risk of developing PTTN. Recent findings suggest that impaired endogenous analgesia may be associated with the development of postsurgical chronic pain. We hypothesized that patients with PTTN display pronociceptive pain modulation, in line with other chronic pain disorders. Dynamic (conditioned pain modulation, temporal summation) and static (response to mechanical and cold stimulation) psychophysical tests were performed intraorally and in the forearm of 27 patients with PTTN and 27 sex- and age-matched controls. The dynamic sensory testing demonstrated less efficient conditioned pain modulation, suggesting reduced function of the inhibitory endogenous pain-modulatory system, in patients with PTTN, mainly in those suffering from the condition for more than a year. The static sensory testing of patients with PTTN demonstrated forearm hyperalgesia to mechanical stimulation mainly in patients suffering from the condition for less than a year and prolonged painful sensation after intraoral cold stimulus mainly in patients suffering from the condition for more than a year. These findings suggest that PTTN is associated more with the inhibitory rather than the facilitatory arm of pain modulation and that the central nervous system has a role in PTTN pathophysiology, possibly in a time-dependent fashion.

Indexed as

Pain ManagementAdultAgedCase-Control StudiesChronic PainFemaleHumansHyperalgesiaMaleMiddle AgedPain MeasurementPsychophysicsTemperatureTrigeminal Nerve Injuries

Identifiers

PMID26098442
PMCPMC4770334
OpenAlexW2396885584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.